Open Access

Harmful effects of carbamazepine on the postnatal development of the rat ventral prostate

  • Samara U Oliva1,
  • Wellerson R Scarano2Email author,
  • Fatima K Okada1 and
  • Sandra M Miraglia1
Reproductive Biology and Endocrinology201210:22

https://doi.org/10.1186/1477-7827-10-22

Received: 19 January 2012

Accepted: 25 March 2012

Published: 25 March 2012

Abstract

Background

Carbamazepine (CBZ) is a first-line antiepileptic drug (AED), although it is also used for the treatments of psychiatric disorders and neuropathic pain. The CBZ utilization has been associated with male reproductive damage, including hormonal alterations, sexual dysfunction and reduction of sperm quality. The wide and long-term use of the CBZ is a common schedule in children and adolescents and alters the testosterone level in adult rats and humans. The objective of this work was to evaluate the CBZ side effects on the ventral prostate of rats from pre-puberty to sexual maturation, since the prostate is an androgen-dependent organ.

Methods

Twenty three day-old male albino Wistar rats received CBZ diluted in propylene glycol (20 mg/Kg/i.p via). The treatment lasted 20, 40 and 70 days, according to the different stages of the rat sexual maturation. At the end of each treatment period, ventral prostates were removed and histologically processed. The prostate sections were submitted to the histopathological, morphological and stereological analyses using image analysis system.

Results

Reductions of the glandular epithelium, glandular lumen and fibromuscular stroma volume of the ventral prostate were observed in adult rats treated with CBZ since the weaning. Triggering and degranulation of mast cells were observed in the fibromuscular stroma of prepubertal and pubertal CBZ treated rats.

Conclusions

The results suggest a direct effect of the CBZ on rat ventral prostate, evidenced by increase of mast cell and macrophage populations during pre-puberty and puberty causing a ventral prostate accentuated damage in the adult phase.

Keywords

CarbamazepineVentral prostateMast cellsStereology

Background

Reproductive endocrine disorders and sexual dysfunction are common in men with epilepsy [1]. In addition, these disorders have been frequently associated with long-term treatments with antiepileptic drugs (AED) [24]. CBZ is a first-line AED also utilized for treatment of psychiatric disorders such as bipolar affective disorder [5], alcohol withdrawal syndrome [6] and neuropathic pain [7].

Various clinical and experimental studies involving the effects of CBZ and other AED on male reproduction have been carried out. They have mainly shown hormonal changes and seminal alterations during adult phase, including reduced sperm motility, sperm morphological alterations and decrease in the sperm concentration [810]. However, studies have not investigated the occurrence of damage to the prostate in the phase of sexual maturation when the CBZ is chronically administered from the pre-pubertal phase.

The reproductive hormone status differs noticeably in humans, according to the phase considered, i.e., in childhood, adolescence and adulthood. Thus, endocrine changes due to long-term CBZ-treatments may cause a negative impact on pubertal development and fertility both in boys and young men [11]. Damage on the seminiferous epithelium, testicular interstitial oedema, reductions of testosterone levels and increase of estradiol levels were also observed in rats treated with CBZ since weaning [12].

The onset and maintenance of prostatic development are androgen-dependent phenomena [13]. However, in rodents, the prostatic development is also sensitive to other hormones such as estrogen and prolactin [1416]. The prostate secretion is important for normal male reproductive function as well as sperm survival within the female reproductive tract during fertilization [14].

The responsive morphological alterations of the prostate to androgen deprivation caused by diabetes [17], chronic alcoholism [18], nicotine [19] and castration [16, 2022] have been shown. In addition, as the chronic administration of CBZ is a common schedule utilized for treatment of children and adolescents [11] and can provoke hormonal alterations as well as damage on fertility [812]. In addition, given that there are not studies investigating the extension of the prostatic damage, caused by CBZ chronic administration, during the sexual maturation, we assumed that this theme is an essential subject to be investigated. Thus, considering that the maturation of the hypothalamic-pituitary-gonadal (HPG) axis in pre-puberty and puberty is more susceptible to a cytotoxic agent [12, 23, 24] and also, taking into account that recently we observed estrogen and testosterone level alterations in CBZ-treated rats from the weaning [12], we proposed to evaluate the side effects of CBZ on the ventral prostate of rats in different phases of sexual development; for this goal, the CBZ was administered to rats from the pre-puberty until the adulthood and the histopathological, morphometric and stereological analyses of their prostate ventral lobe were carried out.

Methods

Animals

Thirty 23-day old male Wistar albino rats were used. The rats were housed in polypropylene cages (40 × 30 × 15 cm) (4 per cage) and had free access to water and commercial lab chow (Labina, Purina). The animals were maintained under controlled photoperiod (12 h light; 12 h dark), humidity (70%) and temperature (22°-23°C). The experimental protocol followed the ethical principles adopted in animal researches by the Brazilian College of Animal Experimentation. The schedule concerning animal care and treatment was approved by the Institutional Ethical Committee of São Paulo University.

Experimental schedules

The animals were randomly distributed into six groups with 5 animals each. The rats were distributed into three control groups (C43, C63 and C93) and three CBZ-treated groups (CBZ43, CBZ63 and CBZ93). Treated rats received CBZ (C-8981, Sigma Chemical Co., St. Louis, MO; 99.5% purity) diluted in propylene glycol (20 mg/ml). The CBZ dose of 20 mg/kg, daily administered by intraperitoneal route (i.p.), corresponds to the usual anticonvulsive dose in humans which is effective in preventing kindled seizure in Wistar rats [25, 26]. The treatment lasted 20, 40 and 70 days, according to the different stages of the rats' sexual maturation, i.e., adolescence (around 43 days; [12, 27]), puberty (63 days; [28, 29]) and young adult phase (93 days; [30]). Control animals received only propylene glycol (vehicle of CBZ). Body weights of control and experimental rats were obtained on alternate days.

Histological procedures

At the end of the different treatment periods, the rats were anesthetized with sodic thiopental (1 ml/kg, Thiopentax, Cristália, Lote 06053324). Heparin (1 ml/Kg) was administered 15 minutes before the euthanasia with anesthetic superdosage (sodic thiopental 3 mg/kg, i.p.), by i.p. route. Blood of the rats was collected from the inferior cava vein and the plasma separated and stored at -20°C for further hormonal analyses. The ventral prostate was removed and weighed. The ventral prostate relative weight (mg of ventral prostate weight/100 g of body weight) was also calculated. The volume of the ventral prostate (Vt) was obtained according to DeKlerk & Coffey's methodology [31], which assumes that the specific gravity of the prostate is 1.0 and thus, 1.0 mg fresh prostate has an approximate volume of 1.0 mm3.

The ventral prostates were adequately fixed by immersion in Bouin's liquid for 48 hours. Prostatic fragments were Paraplast Plus-embedded (P-3683, Sigma Chemical Co., St. Louis, MO, lote 41K0101); five micrometers-thick cross sections were obtained and stained using Mallory Tricromic, for subsequent morphometric and stereological studies. In addition, other five sections were obtained and exposed to toluidine blue staining method and to Perl's solution labeling for respective stereological evaluation and the obtainment of the mast cells and macrophage numerical densities.

Fragments were also embedded in glycol methacrylate resin (Leica Historesin embedding kit); two micrometer-thick longitudinal sections were obtained and submitted to the Hematoxilin and Eosin (HE) staining method for histopathological analysis under light microscope.

Macrophage labeling

For macrophage labeling, paraplast-embedding tissue sections were immersed in Perl's solution containing 2% potassium ferrocyanide and 2% HCl at a 1:1 concentration for 30 min [32]. After PBS rinses and 30 min incubation in 3% hydrogen peroxide/PBS, iron was visualized using 3,3-diaminobenzidine (DAB; Vector) for 30 min at room temperature in the dark [33].

Morphometric and stereological evaluation

Samples of the ventral prostate were obtained according to the orientator to produce an isotropic uniform random (IUR) sample [34, 35]. Each ventral prostate sample was divided into parallel slabs of roughly equal length and each slab was cut into parallel vertical slices. The angle at which the first slab was cut was chosen at random and other slabs were cut in similar fashion after systematically rotating on the horizontal plane, providing an isotropic uniform random section plane. The IUR sections are more random than vertical sections and therefore can be used as vertical sections with cycloids for estimation of length and surface [36].

The morphometric and stereological analyses of the compartments of the prostate ventral lobe were carried out. The volume densities (Vv) of the lumen [Vv(lu)], glandular epithelium or acinar parenchyma [Vv(ep)] and fibromuscular stroma [Vv(st)] were calculated using a Leica QWin (Cambridge, England) image analysis system. Twenty two fields were systematically randomly sampled and the images were captured using a digital camera connected to a light microscope. Examination of isotropic uniform random (IUR) sections of the ventral prostate revealed that the glandular tubules were randomly placed [20]. The Delesse Principle states that the planimetric fraction of a section, which is occupied by sections of a specified component, corresponds to the fraction of the tissue volume occupied by the same component [37]. For that reason, according to the basic principle of stereology, the area density of the profiles (A A ), which measures the relative occupation of test-area for the area of the images of the structure under evaluation, is comparable to the volume density (Vv), i.e., the density of profiles in relation to the space; consequently, Vv and A A have similar interpretation [3740]. Thus, from the captured images, the ventral prostate lumen, glandular epithelium and fibromuscular stroma areas were delineated, utilizing the image analysis system. Then, based on the principles of stereology, each specific volume density (Vv) was respectively obtained by the ratio of the delineated area of the ventral prostate (lumen, glandular epithelium or fibromuscular stroma compartment) to the total area of the prostate component analyzed. In addition, the volumes (V) of the lumen (V lu), glandular epithelium (V ep) and fibromuscular stroma (V st) of the ventral prostate were estimated by multiplying each respective volume density (in percentage) by the prostate total volume (in "Histological procedures" item) and dividing the result by 100 [29].

The determination of length density (Lv) of the glandular tubule (Lvgt) and surface density of the glandular epithelium tubule (Svgt) were also performed [21]. To measure the length density of the glandular tubules (Lvgt), we firstly calculated the profile density of the structure evaluated (QA), i.e., the number of glandular tubule profiles per area unit was counted. For this purpose, an amount of images of these structures (sections of glandular tubules) was estimated in a certain test-area defined by an unbiased counting frame with inclusion (right and upper) and exclusion (left and lower) borders; thus, a reliable square test-area was superimposed on the microscopic images IUR ventral prostate section captured and shown by the monitor screen of the image analysis system. Twenty two fields were systematically randomly sampled. Following, the number of glandular tubule profiles inside the total test area was counted (QA). All structures falling on the two set forbidden lines were not counted to avoid overestimation. Subsequently, the glandular tubule length density (Lvgt) was obtained by the formula: Lvgt = 2 * QA [35]. The total length (L) of glandular tubules (Lgt) was also calculated using the formula: Lgt = Lvgt x Vt, where Lvgt corresponds to the glandular tubule length density [35] and Vt is the ventral prostate total volume obtained as formerly referred. The total area analyzed was obtained by multiplying the area of the test grid (1874.75 mm2) by the number of fields analyzed (23 fields) utilizing ×20 objective lens.

The surface density of the glandular epithelium Svep was obtained by counting the number of intercepts of the cycloid test lines with luminal border of the glandular epithelium using a cycloid test grid [37]. Then, the glandular epithelium surface (Sep) was calculated by multiplying Svep by the ventral prostate total volume (Vt) and dividing this result by 100 [20].

Numerical densities of mast cells and macrophages

Twenty two fields were systematically randomly sampled and the images were captured using a computer assisted image analysis system (Leica-Q550IW; Cambridge-England) coupled to a light microscope. Both macrophage (Perl's solution labeling) and mast cells (toluidine blue staining) counts were attained by Optical Disector method. Considering that the numerical density (Nv) is expressed by units of volume and corresponds to the ratio of total number of scored cells to total volume of tissue examined (V), the numbers of macrophage and mast cells per mm3 of fibromuscular stroma were obtained. The volume of the fibromuscular stroma (v) was estimated by multiplying the respective areas delineated (in mm2) by thickness cross sections (in mm). Thus, the numerical density (Nv) is expressed by units of volume and corresponds to the ratio between the total number of scored macrophage/mast cells and volume of fibromuscular stroma examined. Counts of macrophage and mast cells were conducted. To avoid overestimation, we scrutinized the testicular tissue by focusing only on one chosen plane (the look-up plane; [41]); thus, only the tissue viewed on this plane was submitted to stereological analysis [42].

Immunohistochemistry (IHC)

AR (SC-816, rabbit polyclonal IgG, epitope mapping at the N-terminus of AR, Santa Cruz Biotechnology, USA) primary antibody was used for immunohistochemistry (IHC). The IHC reaction was performed using the avidin-biotin complex (ABC) kit (Santa Cruz Biotechnology, CA, USA). For the immunohistochemical technique, the ventral prostate fragments were previous adequately fixed by immersion in Bouin's liquid and processed for paraplast-plus embedding (P-3683; Sigma Chemical Co., lote 41K0101). The sections (5 μm) were dewaxed and then rehydrated in alcohol graded solution and distilled water. Antigenic retrieval was realized in citrate buffer at high temperature (100°C) for 45 minutes. Endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide in methanol for 45 min, followed by a quick rinse in distilled water and phosphate-buffered saline (PBS), and then incubated in 1% bovine serum in PBS for 1 h, to block non-specific binding. Sections were incubated with the primary antibody at 4°C overnight. The slides were then incubated with biotinylated secondary antibody at 37°C followed by peroxidase-conjugated avidin-biotin complexes and diaminobenzidine (DAB). The sections were then counterstained with Harris's hematoxylin. For negative control, the primary antibody was replaced with the corresponding normal isotype serum.

AR semi-quantitative analysis

At least five histological sections were analyzed per group and AR positive nuclei were randomly selected by section (100 nuclei/group). The images of the selected nuclei were cut in a regular and constant rectangular form (always in central part of the nucleus, in view of the homogeneity of nuclear staining/reactivity for AR) and those "rectangles" were submitted to optical densitometry analysis by Scion Image for Windows Software®. The integrated optical density (IOD) methodological proceedings were based on physical principles of quantification performed [39].

Hormonal levels

Testosterone and estradiol plasmatic levels were determined by radioimmunoassay method using Coat-A-Count Total Testosterone kit and Coat-A-Count Total Estradiol kit (Diagnostic Products Corp., LA, CA, USA). The sensitivity of all Kits utilized was 0.01 ng/mL.

Statistical analysis

Data obtained from the treated and control groups were compared using two-way ANOVA; post hoc "t" parametric test (Student test) or the non-parametric Mann-Whitney tests were utilized. The differences were considered statistically significant when p ≤ 0.05.

Results

Morphometric and stereological evaluation

Treatment with CBZ caused a significant decrease in the ventral prostate absolute weight of the CBZ93 rats in comparison to the respective C93 control rats. In addition, prostatic volume and total length of glandular tubules also significantly diminished in the CBZ93 rats. On the other hand, the absolute and relative weights of the ventral prostate as well as the prostatic volume and length of rats from the other CBZ-treated groups (CBZ43 and CBZ63) did not show significant statistical differences in comparison to their control groups (Table 1).
Table 1

Prostatic morphometric and stereological evaluation

Groups

Absolute prostatic weight

(mg)

Relative prostatic weight

(mg/100 g b.w.)

Prostatic volume (mm3)

Lvgt(1/mm2)

Lgt(mm)

C43

110.50 ± 26.25

66.11 ± 14.38

110.50 ± 26.25

27.10 ± 5.61

2,97 ± 0.84

CBZ43

87.60 ± 8.56

60.08 ± 3.83

87.60 ± 8.56

32.70 ± 6.56

2.89 ± 0.77

C63

245.72 ± 21.64

83.80 ± 7.95

245.72 ± 21.64

23.10 ± 2.36

5.71 ± 1.05

CBZ63

231.00 ± 9.17

81.48 ± 5.91

231.00 ± 9.17

20.40 ± 5.99

4.70 ± 1.35

C93

423.08 ± 74.44

12.24 ± 0.32

423.08 ± 74.44

19.10 ± 2.75

8.07 ± 1.79

CBZ93

260.24 ± 46.80*

12.01 ± 0.67

260.24 ± 46.80*

21.50 ± 4.03

5.56 ± 1.47*

Data are reported as mean ± SD.

Differences statistically significant: *p ≤ 0.05

Prostate absolute and relative weights, prostate volume, length density (Lvgt) and length (Lgt) of the prostate glandular tubules in the control and CBZ-treated groups

Reductions of the volume of the ventral prostate glandular lumen, and of glandular epithelium and fibromuscular stroma were also observed in the CBZ93 group comparatively to their respective control rats (Table 2). Moreover, a decrease in the surface density (Sv) and surface (S) of the epithelium of the glandular tubules were also noted in the CBZ93 group (Figures 1 and 2).
Table 2

Volume density (Vv) and total volume (V)

Stereological and morphometric

parameters

Groups

 

C93

CBZ93

Vv glandular epithelium (%)

39.14 ± 5.90

38.69 ± 4.68

Vv glandular lumen (%)

43.31 ± 9.40

41.83 ± 6.67

Vv fibromuscular stroma (%)

17.55 ± 5.34

19.49 ± 2.79

V glandular tubule epithelium (mm3)

162.47 ± 14.99

101.11 ± 22.88*

V glandular lumen (mm3)

188.69 ± 70.08

108.38 ± 22.26*

V fibromuscular stroma (mm3)

71.92 ± 13.46

50.74 ± 11.86*

Data are reported as mean ± SD; n = 5. Statistically significant differences: *p ≤ 0.05

Volume density (Vv) and total volume (V) of the prostatic glandular epithelium, glandular lumen and fibromuscular stroma in the C93 control and CBZ93 groups

Figure 1

Surface density (Sv) of the glandular tubule epithelium of the (Sv gt ) in the prostate of control and CBZ-treated rats. Surface density (Sv) of the glandular tubule epithelium of the (Svgt) in the prostate of control and CBZ-treated rats. Mean ± SD; n = 5. Statistically significant differences: *p ≤ 0.05.

Figure 2

Surface (S) of the epithelium of the prostatic glandular tubules (S gt ) in the control and CBZ-treated groups. Surface (S) of the epithelium of the prostatic glandular tubules (Sgt) in the control and CBZ-treated groups. Mean ± SD; n = 5. Statistically significant differences: *p ≤ 0.05.

The volume and volume density of the ventral prostate lumen, epithelium of the glandular tubules and stroma compartments of the CBZ63 and CBZ43 did not show significant alterations in comparison with the control rats of the same age (data not shown).

Histological analysis and numerical densities of mast cells and macrophages

The sections of the rat ventral prostate of all control and CBZ-treated groups showed acini surrounded by a fibromuscular stroma, which frequently showed secretion within the lumen. In all groups, the mucosa of the ventral prostate was typically folded showing tall columnar secretory epithelial cells (Figures 3A, E). In the fibromuscular stroma, layers of smooth muscle fibers were observed involving the acini; outer and extensive connective tissue surrounded these structures (Figures 3A-F). Mast cells were found in the stroma of the control (Figures 3A, C, E) and CBZ-treated animals (Figures 3B, D, F and 4A-C). However, cytoplasm of mast cells showed accentuated granules in CBZ43 (Figure 3B) and CBZ63 groups (Figures 3D and 4B, C). Frequently, the granules appeared to be releasing into the connective tissue, suggesting an activation of the mast cells (Figure 3D and 4C). Nevertheless, the CBZ93 rats (Figure 3F) showed mast cells with similar morphological characteristics when compared to those of the C93 control group (Figure 3E). Moreover, the numerical density of mast cells was significantly higher in CBZ63 and CBZ93 groups in comparison to corresponding controls groups (Figure 5).
Figure 3

Photomicrographs of ventral prostate sections of control and CBZ treated rats at different ages. HE-method. A: Part of ventral prostate section of 43-day old control rat, showing glandular epithelium with tall columnar secretory epithelial cells (Ep), smooth muscle layers (thin arrow) and connective tissue (asterisks). Note the presence of no activated mast cell in the fibromuscular stroma (thick arrow). Bv: blood vessel. Bar: 9 μm. B: Part of ventral prostate section of CBZ43 rat. Note the mast cell in the fibromuscular stroma with visible cytoplasmatic granules (thick arrow). Bar: 9 μm. C: Part of ventral prostate section of a 63-day old control rat, showing detail of the fibromuscular stroma (asterisk) containing mast cell (thick arrow) with no conspicuous cytoplasmatic granules. Bar: 9 μm. D: Ventral prostate section of the CBZ63 rat. Note the various mast cells in process of degranulation (thick arrows) disposed in the fibromuscular stroma (asterisk). Bar: 10 μm. E and F: Ventral prostate sections of C93 and CBZ93 rats. Note the smooth muscle layers (thin arrows) and the connective tissue (asterisks) containing the mast cells with fine and few evident cytoplasmatic granules (head arrows). Bar: 7 μm and 7 μm, respectively.

Figure 4

Photomicrographs of ventral prostate sections of CBZ-treated rats at different ages. Toluidine blue method. A: Part of ventral prostate sections of the CBZ93 rat showing the fibromuscular stroma with mast cells (arrows) around blood vessel (Bv). Bar: 20 μm. B and C: Ventral prostate sections of the CBZ63 rats. Note mast cells with fine cytoplasmatic granules (4b, head arrows), mast cells in degranulation process (4c, arrows) and cytoplasmatic granules (asterisks) distributed into the fibromuscular stroma. Bar: 18 μm and 11 μm, respectively.

Figure 5

Numerical density of the mast cells in the prostatic fibromuscular stroma in the control and CBZ-treated groups. Mean ± SD; n = 5. Statistically significant differences: *p ≤ 0.05.

Macrophages were also located in the fibromuscular stroma of the control and CBZ-treated animals with 43, 63 and 93 days (Figures 6A, B). However, although the macrophage numerical density of the CZB63 group has shown a significant increase in comparison to the C63 control group, an evident reduction of this parameter occurred in the 93-day old CBZ-treated rats in relation to the C93 control rats (Figure 7).
Figure 6

Photomicrographs of ventral prostate sections of CBZ43 and CBZ63 rats, respectively. A and B: Observe the positive staining macrophages (arrows) disposed in the fibromuscular stroma (asterisks). Perl's solution. Bar: 11 μm and 13 μm, respectively.

Figure 7

Numerical density (Nv) of the macrophage on prostatic stroma fibromuscular in the control and CBZ-treated groups. Mean ± SD; n = 5. Statistically significant differences: *p ≤ 0.05.

AR immunohistochemistry

The ventral prostate AR immunoreactivity presented the same pattern of staining in the following control and treated groups: C43 and CBZ43; C63 and CBZ63 (Figures 8A-D). However, AR immunoreactivity was diminished in the CBZ93 group in relation to C93 control group (Figures 8E, F). The optical density of nuclear reactivity confirmed the qualitative analysis and showed decrease in the AR reactivity in the CBZ93 group when compared to the C93 control group (Figure 9).
Figure 8

Photomicrographs of ventral prostate sections of control and CBZ- treated rats at different ages submitted to AR IHC. Brown stain signifies AR positive reactivity. Observe immuno-stainable AR located in the nuclei of cells in the prostate epithelium (arrows); AR immuno-localization showed decrease in staining intensity in 93- day old CBZ-treated rats when compared with their control rats. Ep: glandular epithelium; Lu: glandular lumen. Bars: 15 μm.

Figure 9

Semi-quantitative analysis (IOD integrated optical density) of the nuclear epithelial cells AR imunoreactivity from ventral prostate in control and CBZ-treated groups. Mean ± SD. Statistically significant differences: *p ≤ 0.05.

Hormonal levels

Plasma testosterone levels were also significantly lower in CBZ63 and CBZ93 rats in comparison with the C63 and C93 control rats (Table 3). Nonetheless, the 93-day-old CBZ-treated rats showed a significant increase in the estradiol plasma levels in comparison with the C93 control group, whereas there was not significant alterations in this hormone level in the 43-day-old and 63-day old CBZ-treated rats, in comparison with their respective control rats (Table 3).
Table 3

Hormonal plasma levels

Groups

Testosterone levels

(ng/dL)

Estradiol levels

(ng/dL)

C43

47.74 ± 8.06

17.19 ± 4.43

CBZ43

41.04 ± 6.9

24.45 ± 5.91

C63

262.64 ± 29.31

13.03 ± 1.39

CBZ63

115.11 ± 35.77*

14.03 ± 2.64

C93

373.99 ± 73.35

12.04 ± 2.32

CBZ93

267.15 ± 70.07*

18.74 ± 2.14*

Data are reported as mean ± SD.

Statistically significant differences: *p ≤ 0.05

Testosterone and estradiol plasma levels in controls (C43, C63 and C93) and CBZ-treated rats (CBZ43, CBZ63 and CBZ93)

Discussion

In the prostate, death and cell proliferation are hormone regulated events. During the periods of normal growth of prostate, androgens are essential for stroma and epithelial cell differentiation throughout branching morphogenesis and ductal canalization [13, 40]. At the age of sexual maturity, the secretory activity of the epithelium and the differentiation of smooth muscle are also maintained by androgens [40]. In the prostate, luminal and basal epithelium as well as stroma and smooth muscle cells express ARs at sexual development and hence are capable of mediating androgen's actions [43]. Thus, in response to androgens, cells of the prostate interact in a autocrine-paracrine way, influencing various aspects of the growth of this gland in normal and diseased states [13]. In fact, differential responsiveness of the prostate to androgens has been observed in rat at different phases of the sexual development [44, 45]. On the other hand, CBZ treatment can cause alterations in the weight of seminal vesicle and prostate gland which are age-dependent; this probably occurs due to the higher responsiveness of the prostate to testosterone during the pre-puberty and adulthood than during the puberty [45, 46]. During the pubertal period, testosterone clearance may be increase and this could account for the apparent reduction in prostate sensitivity during the pubertal period. It is possible that the alterations in prostate response reported are inherent to the tissue themselves and are dependent on their own spontaneous maturation independent of other hormonal events [47].

Puberty in the male rat is a complex process that involves maturational changes in the hypothalamus, pituitary, testes, and secondary sexual organs and in their interrelationships. During the course of sexual maturation, the negative feedback control systems for the gonadotropins become less responsive to testosterone while the testes become more responsive to LH. In the immature rat, testosterone can potentiate the effect of GnRH on pituitary LH release; this response is lost with sexual maturation. The responsiveness of the prostate to testosterone is also altered with age due proportion of testosterone and androstendione secreted by the testes. Experiments designed to prevent or mimic the transition in testicular steroid secretion suggest that it may be a critical component of sexual maturation in the male rat. An increase of androstendione appears to be capable of delaying the maturation of the LH negative feedback system, the prostate gland, and the GnRH self-priming effect [46]. Moreover, the metabolism of testosterone and/or alterations androgen receptor activity could be responsible for these sensibility differences [46]. In addition, estrogens also play a physiologic role in the prostate development with regard to programming stromal cells and directing early morphogenic events [48].

The significant reductions of ventral prostate weight and volume observed in CBZ93 rats probably occurred due to the CBZ-induced hormonal alteration. These data are in accordance with our previous study [12]; in this former study, a decrease in testosterone plasma levels and an increase in the estrogen level were respectively observed in 63 and 93 day-old rats which were also CBZ-treated from the weaning. In addition, the decrease in the weight of androgen-dependent organs as the ventral prostate is consistent with the decrease in serum levels of testosterone [13, 49]. Besides, both androgen and estrogen regulate AR at the level of mRNA and protein. Then, abnormalities in the AR signaling pathway have also been linked to male reproductive alterations [50, 51]. Moreover, post-transcriptional regulation through stability of the mRNA product is believed to be a major mechanism of androgens' effects [52]. In the current work, the CBZ treatment caused decrease in the AR reactivity of the 93-day old rat prostate; this event was confirmed by the optical density of nuclear reactivity. Prins and Birch [50] observed that neonatal chronic estrogen exposure resulted in an immediate and sustained decrease in AR protein levels in the developing and adult rat ventral prostate that in turn led to its abnormal growth and decreased secretory capacity.

In this present study, an increase of the estrogen plasma levels during puberty phase was observed in CBZ-treated rats. In addition, the estrogen plasma levels remained high in the adulthood and this phenomenon probably corroborated the reduction of the morphometric and stereological parameters evaluated. In fact, a decrease in the glandular acini length as well as in the glandular lumen, glandular epithelium and fibromuscular stroma volumes were observed in the CBZ93 group. These phenomena resulted in a reduction of the ventral prostate weight and volume in rats of this group. Additionally, we suggested that the reduction of glandular epithelium surface was a consequence of the diminution of the glandular epithelium volume. Thus, although CBZ chronic treatment since weaning has induced significant prostatic alterations observed in adult rats, the harm was started from the pre-puberty phase.

Similar to androgens, circulating levels of estradiol are high during the fetal and early neonatal life in both humans and rodent models [53] and there is compelling evidence that the developing prostate gland is particularly sensitive to these estrogens. Although the natural role for estrogens during prostatic development is unclear, it has been proposed that excessive estrogenization during prostatic development may contribute to the high incidence of benign prostatic hyperplasia and prostatic carcinoma [54]. Following neonatal exposure to high-dose estradiol, both epithelial and stromal cell proliferation and differentiation are markedly disturbed leading to defects that persist throughout the lifespan of the animal [55, 56]. Neonatal estrogen exposure interrupts intercellular communication and blocks certain epithelial cells within the rat prostate from entering a normal differentiation pathway, beyond that the activational response to androgens during adulthood is permanently blunted in estrogenized rats [57] and this effect is mediated, in part, through an immediate and permanent reduction in prostatic AR expression [55, 5860]. Furthermore, the temporal expression patterns and quantitative levels of several other members of the steroid receptor superfamily are deregulated by early exposure to high doses of estradiol [15].

Besides, the possible direct effects of CBZ should be also considered as this drug is highly lipid-soluble [8, 61]. Furthermore, some drugs alter the prostatic stroma-epithelial communication and this occurrence may affect the expression or distribution of growth factors, steroid hormones, and their respective receptors [13]. These phenomena corroborate the possible occurrence of a specific effect of the CBZ on ventral prostate, independently from the hormonal testosterone and estradiol level alterations caused by this drug.

Although structural alterations of the prostatic tissue have not been noted during the histopathological analysis, we could observe the presence of degranulated mast cells in fibromuscular stroma, both in the CBZ43 and CBZ63 rats.

There are mast cells in almost all organic systems, including lungs, skin, heart, and gastrointestinal tract. Depending on the organic system, differentiation state, stage of maturation as well as pathological conditions, mast cells can be heterogeneous in terms of their phenotype, functional properties, and local distribution [62, 63]. In the ventral prostate, a quantitative analysis revealed a correlation between the numerical density of mast cells and the age of the rat, since their frequency increases during pre-puberty, remaining constant in the puberty and adult phases [64]. Mast cells participate in inflammatory reactions, angiogenesis, extracellular matrix reabsorption [65], fibrosis and tissue reconstruction [66]. Activated mast cells contain several inflammatory mediators, such as histamine, serotonin, cytokines, leukotrienos, prostaglandins, chemotatic substances, platelet-activing factor and potent vasodilators molecules [62]. These mastocitary products may be activated by different stimuli such as chemical substances, drugs, free radicals, estradiol and radiation [67]. Tobacco smoke, for example, can directly activate mast cells and to act releasing mediators such as histamine and tryptase, causing degranulation of mast cells [68, 69].

The hormonal status may also induce activation and degranulation of mast cells. Estrogens can induce rat prostate inflammation [70] and then, mast cells can undergo degranulation [71]. Many experimental studies showed that steroid sexual hormones can influence the immune response and allergy development, in which estrogen is able to enhance humoral immune response and antibody synthesis, whereas androgen seems to exhibit inhibitory effects [7274]. Therefore, the occurrence of activated and degranulated mast cells located in the fibromuscular stroma, of the CBZ63 group might be caused by alterations of the testosterone and estradiol levels.

Since changes of the testosterone or estradiol plasma levels this age were not at 43 days of age, the presence of activated and degranulated mast cells in the prostatic stroma of CBZ43 rats cannot be only explained based on hormonal alterations. Thus, in the our experiment, the frequent observation of activated and degranulated mast cells located in the fibromuscular stroma of the CBZ43 and CBZ63 groups again suggests that a direct effect of the CBZ on ventral prostate may have occurred, inducing possible transitory inflammatory process. In fact, mast cells granules containing preformed tumor necrosis factor α and releasing this cytokine from mast cells is important for the initiation of an inflammatory response [75].

Some experiments indicate that mast cell infiltration can enhance carcinogenesis [76, 77]. Mast cells contribute to the development of skin cancer in K14-HPV16 transgenic mouse by proteases releasing, such as tryptase and chymase and stimulating angiogenesis [78].

In addition, the presence of degranulated mast cells in the prostatic stroma of CBZ63 rats was followed by increase of the macrophages number. This increase of macrophages might partly be due to the cytokines released from infiltrating mast cells. Macrophages have shown clearly to aid in both the initiation and progression of experimental cancers [79]. Similar increases in mast cells and macrophages were observed in rats exposure to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), a heterocyclic amine in cooked meat at high temperatures [80]; then, the inflammatory response to PhIP may help explain the tissue-specific and prostate lobe-specific carcinogenesis in the rat prostate induced by a long term dietary carcinogen [81]. Moreover, after castration, an increase of the mast cells can be observed in the rat prostate; besides, the number of ED-1-immunostained macrophages was also markedly increased in the epithelium and in the stroma of the rat ventral prostate [82].

In the present study, stereological and histomorphometric analyses revealed that CBZ chronic treatment since weaning causes, in the adult phase, decreases in: the volume of prostatic components, glandular epithelium surface and acini lenght. As a result, these alterations may have probably provoked reductions of the ventral prostate weight and volume in response to the CBZ direct effect. Besides, testosterone and estradiol plasma level alterations caused by CBZ can also indirectly act on the ventral prostate, influencing its maintenance and development. In addition, the presence of activated mast cells during pre-puberty and puberty phases may indicate a possible transitory inflammatory process, suggesting direct effect of the CBZ on ventral prostate.

In addition, we must remember that inflammatory reactions of the male genitourinary tract can affect male infertility in different degrees. In fact, high levels of cytokines secreted by mast cells can play a role in the decrease of the sperm function and sperm-egg interaction and this phenomenon have been widely neglected so far. Moreover, cytokines does not act only as key mediators of inflammation, but may also play important roles in the carcinogenesis and cancer progression [83, 84]. Moreover, mast cells have been used as markers for risk stratification in invasive breast cancers [85, 86]; then, it is possible that they can also function as cellular marker in other neoplasm, such as prostate tumor.

Conclusions

Thus, particular attention must be drawn to the exposure to environmental contaminants and therapeutic drugs which can cause hormonal imbalances, injury and chronic inflammation of the prostate, leading to successive infertility and prostate cancer.

Declarations

Acknowledgements

We would like to express our gratitude to FAPESP and CAPES for the financial support.

Authors’ Affiliations

(1)
Department of Morphology and Genetics, Developmental Biology Laboratory, Federal University of São Paulo (UNIFESP)
(2)
Department of Morphology, São Paulo State University (UNESP)

References

  1. Herzog AG, Fowler KM: Sexual hormones and epilepsy: threat and opportunities. Curr Opin Neurol. 2005, 18: 167-172. 10.1097/01.wco.0000162859.42218.fd.View ArticlePubMedGoogle Scholar
  2. Herzog AG, Drislane FW, Schomer DL, Pennell PB, Bromfield EB, Kelly KM, Farina EL, Frye CA: Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs. Epilepsia. 2004, 45: 764-768. 10.1111/j.0013-9580.2004.60703.x.View ArticlePubMedGoogle Scholar
  3. Isojarvi JI, Tauboll E, Herzog AG: Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs. 2005, 19: 207-223. 10.2165/00023210-200519030-00003.View ArticlePubMedGoogle Scholar
  4. Roste LS, Tauboll E, Morkrid L, Bjornenak T, Saetre ER, Morland T, Gjerstad L: Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy. Eur J Neurol. 2005, 12: 118-124. 10.1111/j.1468-1331.2004.00899.x.View ArticlePubMedGoogle Scholar
  5. Albani F, Riva R, Baruzzi A: Carbamazepine clinical pharmacology: a review. Pharmacopsychiatry. 1995, 28: 235-244. 10.1055/s-2007-979609.View ArticlePubMedGoogle Scholar
  6. Stuppaeck CH, Barnas C, Hackenberg K, Miller CH, Fleischhacker WW: Carbamazepine monotherapy in the treatment of alcohol withdrawal. Int Clin Psychopharmacol. 1990, 5: 273-278. 10.1097/00004850-199010000-00004.View ArticlePubMedGoogle Scholar
  7. Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: um update and effect related to mechanism of drug action. Pain. 1999, 83: 389-400. 10.1016/S0304-3959(99)00154-2.View ArticlePubMedGoogle Scholar
  8. Chen SS, Shen MR, Chen TJ, Lai SL: Effects of antiepileptic drugs on sperm motility of normal controls and epileptic patients with long-term therapy. Epilepsia. 1992, 33: 149-153. 10.1111/j.1528-1157.1992.tb02298.x.View ArticlePubMedGoogle Scholar
  9. Isojärvi JI, Lofgren E, Juntunen KS, Pakarinen AJ, Paivansalo M, Rautakorpi I, Tuomivaara L: Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology. 2004, 62: 247-253.View ArticlePubMedGoogle Scholar
  10. Soliman GA, El-Meguid Abd Abla: Effects of antiepileptic drugs carbamazepine and sodium valproate on fertility of male rats. Dtsch Tierärztl Wschr. 1999, 106: 110-113.Google Scholar
  11. Mikkonen K, Tapanainen P, Pakarinen AJ, Paivansalo M, Isojarvi JI, Vainionpaa LK: Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy. Epilepsia. 2004, 45: 769-776. 10.1111/j.0013-9580.2004.04604.x.View ArticlePubMedGoogle Scholar
  12. Oliva SU, Miraglia SM: Carbamazepine damage to rat spermatogenesis in different sexual developmental phases. Int J Androl. 2009, 32: 563-574. 10.1111/j.1365-2605.2008.00898.x.View ArticlePubMedGoogle Scholar
  13. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y: The endocrinology and developmental biology of the prostate. Endocr Rev. 1987, 8: 338-362. 10.1210/edrv-8-3-338.View ArticlePubMedGoogle Scholar
  14. Mann T, Lutwak-Mann C: Male reproductive function and semen. 1981, Berlin: Springer VerlagView ArticleGoogle Scholar
  15. Prins GS, Birch L, Tang WY, Ho SM: Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol. 2007, 23: 374-382. 10.1016/j.reprotox.2006.10.001.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Scarano WR, Sousa DE, Campos SGP, Corradi LS, Vilamaior PSL, Taboga SR: Oestrogen supplementation following castration promotes stromal remodelling and histopathological alterations in the Mongolian gerbil ventral prostate. Int J Exp Pathol. 2008, 89: 25-37.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Carvalho CA, Camargo AM, Cagnon VH, Padovani CR: Effects of experimental diabetes on the structure and ultrastructure of the coagulating gland of C57BL/6 J and NOD mice. Anat Rec A Discov Mol Cell Evol Biol. 2003, 270: 129-136.View ArticlePubMedGoogle Scholar
  18. Sáttolo S, Carvalho CA, Cagnon VH: Influence of hormonal replacement on the ventral lobe of the prostate of rats (Rattus norvegicus albinus) submitted to chronic ethanol treatment. Tissue Cell. 2004, 36 (6): 417-430. 10.1016/j.tice.2004.07.004.View ArticlePubMedGoogle Scholar
  19. Carvalho CA, Favaro WJ, Padovani CR, Cagnon VH: Morphometric and ultrastructure features of the ventral prostate of rats (Rattus norvegicus) submitted to long-term nicotine treatment. Andrologia. 2006, 38: 142-151. 10.1111/j.1439-0272.2006.00728.x.View ArticlePubMedGoogle Scholar
  20. Romppanen T, Huttunen E, Helminen HJ: An improved light microscopical histoquantitative method for the stereological analysis of the rat ventral prostate lobe. Invest Urol. 1980, 18: 59-65.PubMedGoogle Scholar
  21. Huttunen E, Romppanen T, Helminen HJ: Testosterone action on the ventral prostate lobe of the castrated rat as assessed with a stereologic morphometric method. Am J Anat. 1982, 165: 199-209. 10.1002/aja.1001650208.View ArticlePubMedGoogle Scholar
  22. Vilamaior PSL, Felisbino SL, Taboga SR, Carvalho HF: Collagen fiber reorganization in the rat ventral prostate following androgen deprivation: a possible role for smooth muscle cells. Prostate. 2000, 45: 253-258. 10.1002/1097-0045(20001101)45:3<253::AID-PROS8>3.0.CO;2-P.View ArticlePubMedGoogle Scholar
  23. Cicero TJ, Adams ML, O'Connor L, Nock B, Meyer ER, Wozniak D: Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny. J Pharmacol Exp Ther. 1990, 255: 707-715.PubMedGoogle Scholar
  24. Oliva SU, Messias AG, Silva DA, Pereira OC, Gerardin DC, Kempinas WG: Impairment of adult male reproductive function in rats exposed to ethanol since puberty. Reprod Toxicol. 2006, 22: 599-605. 10.1016/j.reprotox.2006.04.017.View ArticlePubMedGoogle Scholar
  25. Lahtinen H, Ylinen A, Lukkarinen U, Sirviö J, Miettinen R, Riekkinen P: Failure of carbamazepine to prevent behavioral and histopathological sequels of experimentally induced status epilepticus. Eur J Pharmacol. 1996, 297: 213-218. 10.1016/0014-2999(95)00742-3.View ArticlePubMedGoogle Scholar
  26. Otsuki K, Morimoto K, Sato K, Yamada N, Kuroda S: Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats. Epilepsy Res. 1998, 31: 101-112. 10.1016/S0920-1211(98)00018-7.View ArticlePubMedGoogle Scholar
  27. Wang R, Chang JS, Zhou XM, Chen DY: Varicocele in the rat: a new experimental model. Effect on histology, ultrastructure and temperature of the testis and the epididymis. Urol Res. 1991, 19: 319-322. 10.1007/BF00299069.View ArticlePubMedGoogle Scholar
  28. Clegg EJ: The age at which male rats become fertile. J Reprod Fertil. 1960, 1: 119-120.Google Scholar
  29. Stumpp T, Freymüller E, Miraglia SM: Sertoli cell function in albino rats treated with etoposide during prepubertal phase. Histochem Cell Biol. 2006, 126: 353-361. 10.1007/s00418-006-0168-3.View ArticlePubMedGoogle Scholar
  30. Miraglia SM, Hayashi H: Histomorphometry of immature rats testis after eating. J Morphol. 1993, 217: 65-74. 10.1002/jmor.1052170106.View ArticlePubMedGoogle Scholar
  31. DeKlerk DP, Coffey DS: Quantitative determination of prostatic epithelial and stromal hyperplasia by a new technique. Biomorphometrics. Investig Urol (Berl). 1978, 16: 240-245.Google Scholar
  32. Stoll G, Wesemeier C, Gold R, Solymosi L, Toyka KV, Bendszus M: In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging. J Neuroimmunol. 2004, 149: 142-146. 10.1016/j.jneuroim.2003.12.024.View ArticlePubMedGoogle Scholar
  33. Schonberg DL, McTigue DM: Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol. 2009, 218: 64-74. 10.1016/j.expneurol.2009.04.005.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Mattfeld T, Möbius HJ, Mall G: Orthogonal triplet probes: an efficient method for unbiased estimation of length and surface of objects with unknown orientation in space. J Microsc. 1985, 139: 279-289. 10.1111/j.1365-2818.1985.tb02644.x.View ArticleGoogle Scholar
  35. Gundersen HJG, Bendtse TF, Korbo L: Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 1988, 96: 379-394. 10.1111/j.1699-0463.1988.tb05320.x.View ArticlePubMedGoogle Scholar
  36. Mattfeld T, Mall G, Gharehbaghi H, Möller P: Estimation of surface area and length with the orientator. J Microsc. 1990, 159: 301-317. 10.1111/j.1365-2818.1990.tb03036.x.View ArticleGoogle Scholar
  37. Weibel ER, Kistler GS, Scherle WF: Practical stereological methods for morphometric cytology. J Cell Biol. 1966, 30: 23-38. 10.1083/jcb.30.1.23.PubMed CentralView ArticlePubMedGoogle Scholar
  38. Mandarim-de-Lacerda CA: What is the interest of normal and pathological morphological research to be quantitative? The example of the stereology. Braz J Morphol Sci. 1999, 16: 131-139.Google Scholar
  39. Zhu LJ, Hardy MP, Inigo IV, Huhtaniemi I, Bardin CW, Moo-Young AJ: Effects of androgen on androgen receptor expression in rat testicular and epididymal cells: a quantitative immunohistochemical study. Biol Reprod. 2000, 63: 368-376. 10.1095/biolreprod63.2.368.View ArticlePubMedGoogle Scholar
  40. Hayward S, Rosen M, Cunha G: Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol. 1997, 79: 18-26.View ArticlePubMedGoogle Scholar
  41. Cruz-Orive LM, Weibel ER: Recent stereological methods for cell biology: a brief survey. Am J Physiol. 1990, 258: L148-L156.PubMedGoogle Scholar
  42. Stumpp T, Sasso-Cerri E, Freymüller E, Miraglia SM: Apoptosis and testicular alterations in albino rats treated with etoposide during the prepubertal phase. Anat Rec. 2004, 279A: 611-622. 10.1002/ar.a.20045.View ArticleGoogle Scholar
  43. Prins GS, Birch L, Greene GL: Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology. 1991, 129: 3187-3199. 10.1210/endo-129-6-3187.View ArticlePubMedGoogle Scholar
  44. Chung LW, MacFadden DK: Sex steroids imprinting and prostatic growth. Invest Urol (Berl). 1980, 17: 337-342.Google Scholar
  45. Vilamaior PS, Taboga SR, Carvalho HF: Postnatal Growth of the Ventral Prostate in Wistar Rats: A Stereological and Morphometrical Study. Anat Rec. 2006, 288A: 885-892. 10.1002/ar.a.20363.View ArticleGoogle Scholar
  46. Nazian SJ, Mahesh VB: Hypothalamic, pituitary, testicular, and secondary organ functions and interactions during the sexual maturation of the male rat. Arch Androl. 1980, 4: 283-303. 10.3109/01485018008986974.View ArticlePubMedGoogle Scholar
  47. Nazian J, Mahesh VB: Alterations in end organ responsiveness to testosterone during the sexual maturation of the male rat. Biol Reprod. 1979, 21: 465-471. 10.1095/biolreprod21.2.465.View ArticlePubMedGoogle Scholar
  48. Prins GS, Huang L, Birch L, Pu Y: The role of estrogens in normal and abnormal development of the prostate gland. Ann N Y Acad Sci. 2006, 1089: 1-13. 10.1196/annals.1386.009.PubMed CentralView ArticlePubMedGoogle Scholar
  49. Corbier P, Martikainen P, Pestis J, Härkönen P: Experimental research on the morphofunctional differentiation of the rat ventral prostate: roles of the gonads at birth. Arch Physiol Biochem. 1995, 103: 699-714. 10.3109/13813459508998139.View ArticlePubMedGoogle Scholar
  50. Prins GS, Birch L: Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology. 1997, 138: 1801-1809. 10.1210/en.138.5.1801.PubMedGoogle Scholar
  51. Feldman BJ, Feldman D: The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001, 1: 34-45. 10.1038/35094009.View ArticlePubMedGoogle Scholar
  52. Prins GS: Molecular biology of the androgen receptor. Mayo Clin Proc. 2000, 75: S32-S35.PubMedGoogle Scholar
  53. Dohler KD, Wuttke W: Changes with age in levels of serum gonadotropins, prolactin, and gonadal steroids in prepubertal male and female rats. Endocrinology. 1975, 97: 898-907. 10.1210/endo-97-4-898.View ArticlePubMedGoogle Scholar
  54. Santti R, Newbold RR, Makela S, Pylkkanen L, McLachlan JA: Developmental estrogenization and prostatic neoplasia. Prostate. 1994, 24: 67-78. 10.1002/pros.2990240204.View ArticlePubMedGoogle Scholar
  55. Prins GS, Birch L: The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology. 1995, 136: 1303-1314. 10.1210/en.136.3.1303.PubMedGoogle Scholar
  56. Chang WY, Wilson MJ, Birch L, Prins GS: Neonatal estrogen stimulates proliferation of periductal fibroblasts and alters the extracellular matrix composition in the rat prostate. Endocrinology. 1999, 140: 405-415. 10.1210/en.140.1.405.PubMedGoogle Scholar
  57. Rajfer J, Coffey DS: Effects of neonatal steroids on male sex tissues. Invest Urol. 1979, 17: 3-8.PubMedGoogle Scholar
  58. Prins GS: Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression. Endocrinology. 1992, 130: 3703-3714. 10.1210/en.130.6.3703.View ArticlePubMedGoogle Scholar
  59. Prins GS, Woodham C, Lepinske M, Birch L: Effects of neonatal estrogen exposure on prostatic secretory genes and their correlation with androgen receptor expression in the separate prostate lobes of the adult rat. Endocrinology. 1993, 132: 2387-2398. 10.1210/en.132.6.2387.PubMedGoogle Scholar
  60. Woodham C, Birch L, Prins GS: Neonatal estrogens down regulate prostatic androgen receptor levels through a proteosome-mediated protein degradation pathway. Endocrinology. 2003, 144: 4841-4850. 10.1210/en.2003-0035.View ArticlePubMedGoogle Scholar
  61. Okumura K, Lee IP, Dixon RL: Permeability of selected drugs and chemicals across the blood-testis barrier of the rat. J Pharmacol Exp Ther. 1975, 194: 89-95.PubMedGoogle Scholar
  62. Galli SJ: New concepts about the mast cell. N Engl J Med. 1993, 328: 257-265. 10.1056/NEJM199301283280408.View ArticlePubMedGoogle Scholar
  63. Weidner N, Austen KF: Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites. J Invest Dermatol. 1991, 96: 26S-30S. 10.1111/1523-1747.ep12468966.View ArticleGoogle Scholar
  64. Hammel I, Roizman P, Massas R, Abramovici A: Ontogeny of mast cells in the ventral prostate of the rat. Int Arch Allergy Appl Immunol. 1990, 93: 212-215. 10.1159/000235303.View ArticlePubMedGoogle Scholar
  65. Trabucchi E, Radaelli E, Marazzi M, Foschi D, Musazzi M, Veronesi AM, Montorsi W: The role of mast cells in wound healing. Int J Tissue React. 1988, 10: 367-372.PubMedGoogle Scholar
  66. Michel P, Van Velthoven R, Petein M, Gras S, Etievant C, Pasteels JL, Kiss R: Influence of suramin alone or in combination with DHT and PDGF on the cell proliferation of benign and malignant human prostatic tissues in organ cultures. Anticancer Res. 1991, 11: 2075-2078.PubMedGoogle Scholar
  67. Theoharides TC, Kempuraj D, Sant GR: Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology. 2001, 57: 47-55. 10.1016/S0090-4295(01)01129-3.View ArticlePubMedGoogle Scholar
  68. Thomas PS, Wilson AN, Schreck RE, Lazarus SC: Prostaglandin D2 production and identification of prostaglandin H synthase within canine mast cell granule. Am J Physiol. 1992, 263: L168-L176.PubMedGoogle Scholar
  69. Johansson S, Landström M, Bjermer L, Henriksson R: Effects of tobacco smoke on tumor growth and radiation response of dunning R3327 prostate adenocarcinoma in rats. Prostate. 2000, 42: 253-259. 10.1002/(SICI)1097-0045(20000301)42:4<253::AID-PROS2>3.0.CO;2-3.View ArticlePubMedGoogle Scholar
  70. Coffey RG, Middleton E: Release of histamine from rat mast cells by lysosomal cationic proteins. Possible involvement of adenylate cyclase and adenosine triphosphatase in pharmacologic regulation. Int Arch Allergy Appl Immunol. 1973, 45: 593-611. 10.1159/000231103.View ArticlePubMedGoogle Scholar
  71. Zaitsu M, Narita S, Lambert KC, Grady JJ, Estes DM, Curran EM, Brooks EG, Watson CS, Goldblum RM, Midoro-Horiuti T: Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol. 2007, 44: 1977-1985. 10.1016/j.molimm.2006.09.030.PubMed CentralView ArticlePubMedGoogle Scholar
  72. Chen W, Mempel M, Schober W, Behrendt H, Ring J: Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy. 2008, 63: 1418-1427. 10.1111/j.1398-9995.2008.01880.x.View ArticlePubMedGoogle Scholar
  73. Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH: Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 2004, 13: 635-638. 10.1191/0961203304lu1094oa.View ArticlePubMedGoogle Scholar
  74. Rettew JA, Huet-Hudson YM, Marriott I: Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod. 2008, 78: 432-437. 10.1095/biolreprod.107.063545.View ArticlePubMedGoogle Scholar
  75. Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol. 2005, 6: 135-142. 10.1038/ni1158.View ArticlePubMedGoogle Scholar
  76. Dimitriadou V, Koutsilieris M: Mast cell-tumor cell interactions: for or against tumour growth and metastasis?. Anticancer Res. 1997, 17: 1541-1549.PubMedGoogle Scholar
  77. Theoharides TC, Conti P: Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 2004, 25: 235-241. 10.1016/j.it.2004.02.013.View ArticlePubMedGoogle Scholar
  78. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D: Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999, 13: 1382-1397. 10.1101/gad.13.11.1382.PubMed CentralView ArticlePubMedGoogle Scholar
  79. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H: A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003, 94: 965-973. 10.1111/j.1349-7006.2003.tb01386.x.View ArticlePubMedGoogle Scholar
  80. Nakai Y, Nelson WG, De Marzo AM: The dietary charred meat carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res. 2007, 67: 1378-1384. 10.1158/0008-5472.CAN-06-1336.View ArticlePubMedGoogle Scholar
  81. Franck-Lissbrant I, Häggström S, Damber JE, Bergh A: Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology. 1998, 139: 451-456. 10.1210/en.139.2.451.PubMedGoogle Scholar
  82. Nishimura K, Kitamura M, Miura H, Nonomura N, Takada S, Takahara S, Matsumoto K, Nakamura T, Matsumiya K: Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction. Prostate. 1999, 41 (3): 145-153. 10.1002/(SICI)1097-0045(19991101)41:3<145::AID-PROS1>3.0.CO;2-R.View ArticlePubMedGoogle Scholar
  83. Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW: Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res. 2007, 67 (9): 4244-4253. 10.1158/0008-5472.CAN-06-3946.View ArticlePubMedGoogle Scholar
  84. Fujita K, Ewing CM, Sokoll LJ, Elliott DJ, Cunningham M, De Marzo AM, Isaacs WB, Pavlovich CP: Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation. Prostate. 2008, 68 (8): 872-882. 10.1002/pros.20755.PubMed CentralView ArticlePubMedGoogle Scholar
  85. Nonomura N, Takayama H, Nishimura K, Oka D, Nakai Y, Shiba M, Tsujimura A, Nakayama M, Aozasa K, Okuyama A: Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br J Cancer. 2007, 97 (7): 952-956.PubMed CentralPubMedGoogle Scholar
  86. Rajput AB, Turbin DA, Cheang MC, Voduc DK, Leung S, Gelmon KA, Gilks CB, Huntsman DG: Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases. Breast Cancer Res Treat. 2008, 107 (2): 249-257. 10.1007/s10549-007-9546-3.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Oliva et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement